STPase 1500000 IU (Streptokinase Injection IP)

Send Inquiry

Request To Call Back

STPase 1500000 IU (Streptokinase Injection IP)

Get a Price/Quote

MOQ : 10 Vials

STPase 1500000 IU (Streptokinase Injection IP) Specification

Brand Name
STPase

Origin of Medicine
India

Life Span
Refer to expiry date on pack

Indication
Acute myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thromboembolism

Salt Composition
Streptokinase

Dosage Form
Lyophilized powder for injection

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Prescription Allopathic Medicine

Ingredients
Streptokinase

Physical Form
Injection

Function
Thrombolytic agent, dissolves clots

Recommended For
Thrombolytic therapy, management of acute myocardial infarction and other types of thrombosis

Dosage
As prescribed by a healthcare professional

Dosage Guidelines
Administered intravenously under medical supervision

Suitable For
Adults

Quantity
1500000 IU

Storage Instructions
Store below 25C, protect from light

Prescription Required
Yes

Packaging Type
Carton with vial

Side Effects
Bleeding, hypotension, allergic reactions

Shelf Life
As per printed expiry date or usually 2 years from date of manufacture

Therapeutic Class
Fibrinolytic agent

Contraindications
Active internal bleeding, recent cerebrovascular accident, bleeding disorders

Manufactured By
Sami Pharmaceuticals Pvt. Ltd.

Marketed By
STPase

Route of Administration
Intravenous infusion

Reconstitution
To be reconstituted with sterile water for injection before use

STPase 1500000 IU (Streptokinase Injection IP) Trade Information

Minimum Order Quantity
10 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Vials Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About STPase 1500000 IU (Streptokinase Injection IP)

Seize this Last Chance to experience the transcendent efficacy of STPase 1500000 IU (Streptokinase Injection IP). This superior, prescription-only fibrinolytic agent is formulated for intravenous infusion, offering noble thrombolytic action in acute myocardial infarction, pulmonary embolism, and other critical thromboses. Customizable for each patient, STPase is presented as a lyophilized powder, reconstituted with sterile water before administration. Manufactured and marketed by Sami Pharmaceuticals Pvt. Ltd., each carton contains a single vial for secure storage. Reserve your supply now for advanced, compassionate thrombolytic therapy.

Material Features and Specific Usage of STPase 1500000 IU

STPase 1500000 IU is crafted with noble precision as a lyophilized Streptokinase powder, ensuring reliable dissolution of harmful clots. Specifically recommended for the management of acute myocardial infarction, pulmonary embolism, and deep vein thrombosis, its application shines in hospitals, critical care units, and emergency settings. The product is administered under expert medical supervision, guaranteeing both safety and efficacy during life-threatening thrombolytic events.

Dispatch, Transportation, and Certification for STPase 1500000 IU Shipment

STPase 1500000 IU is promptly dispatched from certified facilities in India, typically shipped within industry-standard lead times to your specified location. Transportation follows strict safety protocols to maintain the medicine's noble quality. Each shipment includes essential certifications, ensuring superior standards are upheld throughout transit and delivery. The product is packed carefully in a protected carton, arriving intact and ready for use by licensed medical professionals.

FAQ's of STPase 1500000 IU (Streptokinase Injection IP):

Q: How is STPase 1500000 IU (Streptokinase Injection IP) administered?

A: STPase is administered through intravenous infusion after being reconstituted with sterile water by a trained healthcare provider, always under strict medical supervision.

Q: What are the main indications for using STPase 1500000 IU?

A: STPase is indicated for the management of acute myocardial infarction, pulmonary embolism, deep vein thrombosis, and arterial thromboembolism, providing rapid thrombolytic therapy in critical situations.

Q: When should STPase 1500000 IU not be used?

A: STPase should not be administered in cases of active internal bleeding, recent cerebrovascular accidents, or other bleeding disorders, as these conditions may increase risk.

Q: Where can STPase 1500000 IU be applied or used?

A: STPase is typically used in hospitals, emergency departments, and critical care environments where rapid intervention for thrombotic events is essential.

Q: What is the process for reconstituting STPase 1500000 IU before use?

A: The lyophilized powder is reconstituted by adding an appropriate amount of sterile water for injection, following the guidelines provided by the manufacturer and healthcare protocols.

Q: What benefits does STPase 1500000 IU offer compared to other thrombolytic agents?

A: STPase offers superior efficacy in dissolving clots quickly, potentially improving outcomes in patients with life-threatening thrombotic conditions when administered promptly by professionals.

Tell us about your requirement